Analytical Data
-
基因名
BCMP11
- Application
-
别名
AG-3; AG3; Agr3; AGR3_HUMAN; Anterior gradient 3; xenopus; homolog of; Anterior gradient homolog 3
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8TD06
-
表达区间
1-166aa
-
氨基酸序列
MMLHSALGLCLLLVTVSSNLAIAIKKEKRPPQTLSRGWGDDITWVQTYEEGLFYAQKSKKPLMVIHHLEDCQYSQALKKVFAQNEEIQEMAQNKFIMLNLMHETTDKNLSPDGQYVPRIMFVDPSLTVRADIAGRYSNRLYTYEPRDLPLLIENMKKALRLIQSEL
-
分子量
45.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BCMP11 is a recombinant protein derived from the family of bacterial chaperones, known for its potential applications in biotechnology and medicine. Research on BCMP11 began to address the challenges associated with protein misfolding and aggregation, which can impede the effectiveness of therapeutic proteins. This recombinant protein is believed to enhance the solubility and stability of other proteins, facilitating their proper folding during expression in host systems such as bacteria or yeast. Moreover, BCMP11 has garnered interest due to its role in cellular stress responses, making it a candidate for improving the yield and functionality of biopharmaceuticals. Studies have shown that the application of BCMP11 can lead to enhanced protein production and better post-translational modifications, essential for the activity of many therapeutic proteins. Investigating BCMP11 also opens avenues for understanding protein interactions under stress conditions, providing insights into fundamental biological processes like protein homeostasis. Ultimately, research on BCMP11 not only contributes to advancing protein engineering techniques but also holds promise for improving the manufacturing processes of biologics, addressing a growing need for efficient production systems in the pharmaceutical industry.
